Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.

Also called NCT01445171

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 295 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01445171
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01445171. Allocation not applicable; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2017-12 (actual). Results posted on 2020-02-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve
Acronym
TRITON
Condition
Aortic Valve Stenosis With Insufficiency
Condition
Aortic Valve Stenosis
Intervention (Device)
Aortic Valve Replacement with EDWARDS INTUITY Valve System
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct01445171
Content hash
57f02e8d7613089ad3a32e9a14a110eb234449ea6fe720d79ddedaed3c75ee8a